Found: 23
Select item for more details and to access through your institution.
Long-Term Survival of Over 6 Years with Afatinib Sequential Treatment in a Patient with EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Case Report.
- Published in:
- 2021
- By:
- Publication type:
- Letter
MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00245-y
- By:
- Publication type:
- Article
Afatinib in EGFR TKI-Naïve Patients with Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Pooled Analysis of Three Phase IIIb Studies.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.709877
- By:
- Publication type:
- Article
Complex ALK Fusions Are Associated With Better Prognosis in Advanced Non-Small Cell Lung Cancer.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.596937
- By:
- Publication type:
- Article
Circulating tumor cells dynamics during chemotherapy predict survival and response in advanced non-small-cell lung cancer patients.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231167818
- By:
- Publication type:
- Article
Correlation of distribution characteristics and dynamic changes of gut microbiota with the efficacy of immunotherapy in EGFR-mutated non-small cell lung cancer.
- Published in:
- Journal of Translational Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12967-024-05135-5
- By:
- Publication type:
- Article
Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Genomic and immune characteristics of HER2‐mutated non‐small‐cell lung cancer and response to immune checkpoint inhibitor‐based therapy.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 8, p. 1581, doi. 10.1002/1878-0261.13439
- By:
- Publication type:
- Article
Effectiveness and Safety of Moxibustion Robots on Primary Dysmenorrhea: A Randomized Controlled Pilot Trial.
- Published in:
- Chinese Journal of Integrative Medicine, 2021, v. 27, n. 8, p. 578, doi. 10.1007/s11655-021-3287-8
- By:
- Publication type:
- Article
Retrospective study on bevacizumab in the treatment of non-small cell lung cancer with brain metastases.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 2, p. 267, doi. 10.1007/s10147-019-01552-5
- By:
- Publication type:
- Article
Plasma extracellular vesicle microRNAs for pulmonary ground-glass nodules.
- Published in:
- Journal of Extracellular Vesicles, 2019, v. 8, n. 1, p. 1, doi. 10.1080/20013078.2019.1663666
- By:
- Publication type:
- Article
Genetic Profiling of Cell-Free DNA From Pleural Effusion in Advanced Lung Cancer as a Surrogate for Tumor Tissue and Revealed Additional Clinical Actionable Targets.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 2, p. 135, doi. 10.1016/j.cllc.2021.09.002
- By:
- Publication type:
- Article
Predictive and Prognostic Potential of TP53 in Patients With Advanced Non-Small-Cell Lung Cancer Treated With EGFR-TKI: Analysis of a Phase III Randomized Clinical Trial (CTONG 0901).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Clinical outcomes of EGFR+/METamp+ vs. EGFR+/METamp‐ untreated patients with advanced non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 11, p. 1619, doi. 10.1111/1759-7714.14429
- By:
- Publication type:
- Article
Association of genetic and immuno-characteristics with clinical outcomes in patients with RET-rearranged non-small cell lung cancer: a retrospective multicenter study.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-00866-6
- By:
- Publication type:
- Article
Association of Cerebrospinal Fluid Tumor DNA Genotyping With Survival Among Patients With Lung Adenocarcinoma and Central Nervous System Metastases.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 8, p. e209077, doi. 10.1001/jamanetworkopen.2020.9077
- By:
- Publication type:
- Article
Heterogeneous responses and resistant mechanisms to crizotinib in ALK‐positive advanced non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 9, p. 1093, doi. 10.1111/1759-7714.12791
- By:
- Publication type:
- Article
Longitudinal Plasma Proteomics-Derived Biomarkers Predict Response to MET Inhibitors for MET-Dysregulated NSCLC.
- Published in:
- Cancers, 2023, v. 15, n. 1, p. 302, doi. 10.3390/cancers15010302
- By:
- Publication type:
- Article
Subsequent treatments beyond progression on osimertinib in EGFR-mutated NSCLC and leptomeningeal metastases.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Do-not-resuscitate orders among advanced-stage Chinese lung cancer patients who died in hospital.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Effect of Dose Adjustments on the Safety and Efficacy of Afatinib in Chinese Patients with EGFR-Mutated Non-Small Cell Lung Cancer Who Participated in the LUX-Lung Clinical Trial Program.
- Published in:
- OncoTargets & Therapy, 2020, v. 13, p. 12539, doi. 10.2147/OTT.S273866
- By:
- Publication type:
- Article
Clinical utility of cerebrospinal fluid-derived circular RNAs in lung adenocarcinoma patients with brain metastases.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC: Final Analysis, with a Focus on Patients Enrolled at Sites in China.
- Published in:
- Targeted Oncology, 2022, v. 17, n. 1, p. 1, doi. 10.1007/s11523-021-00859-6
- By:
- Publication type:
- Article